Corpus ID: 52971878

Long non ‐ coding RNA ferritin heavy polypeptide 1 pseudogene 3 controls glioma cell proliferation and apoptosis via regulation of the microRNA ‐ 224 ‐ 5 p / tumor protein D 52 axis

@inproceedings{Zhang2018LongN,
  title={Long non ‐ coding RNA ferritin heavy polypeptide 1 pseudogene 3 controls glioma cell proliferation and apoptosis via regulation of the microRNA ‐ 224 ‐ 5 p / tumor protein D 52 axis},
  author={Y. Zhang and L. Ying and J. Wang and P. Lei},
  year={2018}
}
  • Y. Zhang, L. Ying, +1 author P. Lei
  • Published 2018
  • The aim of the present study was to investigate the potential role and regulatory mechanism of long non‐coding RNA ferritin heavy polypeptide 1 pseudogene 3 (FTH1P3) in glioma development. The expression of FTH1P3 in low‐ and high‐grade glioma tissues was investigated using reverse transcription‐quantitative polymerase chain reaction. FTH1P3 expression was overexpressed or suppressed in U251 glioma cells to examine the involvement of FTH1P3 in glioma cell proliferation and apoptosis using MTT… CONTINUE READING
    4 Citations

    Figures from this paper

    Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer
    • 17
    • PDF
    RNA sequencing discloses the genome-wide profile of long noncoding RNAs in dilated cardiomyopathy
    • 2
    • PDF

    References

    SHOWING 1-10 OF 33 REFERENCES
    Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p
    • 33
    • PDF
    Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
    • 247
    Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer
    • 57
    Upregulation of microRNA-224 confers a poor prognosis in glioma patients
    • 33
    Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells.
    • 125
    • PDF
    Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets?
    • 235
    • PDF